The updated recommendations include both nonpharmacologic and pharmacologic interventions for adults in the acute phase of MDD.
All articles by Diana Ernst, RPh
The approval was based on data from 2 trials in adults who met DSM-IV-TR or DSM-5 criteria for MDD and had an inadequate response to 1 to 3 courses of prior antidepressant therapy.
The AAP has released a new list of 5 tests and procedures commonly ordered in pediatric emergency medicine that physicians and patients should question.
Xylazine is centrally-acting alpha2-adrengeric agonist that was originally approved in 1972 as a sedative and analgesic for use in veterinary medicine.
Lecanemab is a humanized monoclonal antibody that works by selectively binding to, neutralizing and eliminating soluble toxic amyloid beta aggregates.
An individual is considered fully vaccinated about 2 weeks after the second dose of Jynneos and 4 weeks after receiving ACAM2000.
Evusheld is a combination of 2 long-acting monoclonal antibodies designed to bind to distinct sites on the SARS-CoV-2 spike protein.
NVX-CoV2373 is engineered from the genetic sequence of SARS-CoV-2 using the Company’s recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein.
Researchers used data from the State Unintentional Drug Overdose Reporting System in order to assess trends in gabapentin-involved overdose deaths.
The placebo-controlled ORCA-2 study evaluated the safety and efficacy of cytisinicline as a treatment for smoking cessation in 810 adult smokers.
-
Latest News Your top articles for Sunday
For More Personalized News -
Haymarket Medical NetworkTop Picks
-
Spotlight Course
- Loading...
Continuing Medical Education (CME/CE) Courses